menu ☰
menu ˟

FDA approves new packaging limits for loperamide

20 Sep 2019
The FDA has approved new package size and type limits for the over-the-counter, brand-name tablet and capsule forms of loperamide, a diarrhea drug, restricting each carton to no more than 48 mg and requiring unit-dose blister packaging.According to t...

Click here to view the full article which appeared in

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.